← Back to Search

Behavioural Intervention

CBIT group for Chronic Tic Disorder

N/A
Recruiting
Led By Christine Conelea, PhD, LP
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 10-17 years at time of enrollment
Current chronic motor and/or vocal tics, defined as tics for at least 1 year without a tic-free period of more than 3 consecutive months. Tics must not be due to a medical condition or the direct physiological effects of a substance
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 27 weeks
Awards & highlights

Study Summary

This trial is studying Tourette Syndrome and Persistent Motor/Vocal Tic Disorder in young people. These conditions can cause problems with functioning, emotions, and behavior. The main symptom is chronic tics. The

Who is the study for?
This trial is for young people with tic disorders, including Tourette Syndrome and Chronic Tic Disorder. Participants should be experiencing chronic tics that impact their daily life. The study aims to help them manage their symptoms through a treatment called CBIT.Check my eligibility
What is being tested?
The trial tests Comprehensive Behavioral Intervention for Tics (CBIT), which teaches patients how to control tics using competing motor actions. It involves an 8-session course where the effectiveness of CBIT will be evaluated through various assessments and video recordings.See study design
What are the potential side effects?
Since CBIT is a behavioral intervention rather than a medication, it does not have typical drug side effects. However, participants may experience fatigue or frustration during the learning process of new techniques to manage their tics.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 10 and 17 years old.
Select...
I have had motor or vocal tics for over a year without a break longer than 3 months.
Select...
My tics are at least moderate in severity.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~27 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 27 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in the Total Tic Score on the Yale Global Tic Severity Scale (YGTSS).
Secondary outcome measures
Change resting-state fMRI connectivity of the brain
Components of CBIT sessions
Identify CBIT process elements that contribute to response
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: CBIT groupExperimental Treatment1 Intervention
Participants with chronic TICs

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,391 Previous Clinical Trials
1,553,044 Total Patients Enrolled
Christine Conelea, PhD, LPPrincipal InvestigatorUniversity of Minnesota
Deanna Greene, PhDPrincipal InvestigatorUniversity of California, San Diego
~67 spots leftby Feb 2029
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top